Clinical Trial Update: A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation study evaluating safety and pharmacokinetics of Palifermin in subjects with acute leukemia undergoing hematopoietic stem cell transpla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• Palifermin (palifermin)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Leukemia | Phase 1 | Status: COMPLETED | Results posted: 2012-07-03